Position in ALKS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$5,809,535
+$557,539 QoQ
Shares Held
110,869
-30.3% QoQ
Ownership
0.066%
of shares outstanding
% of Portfolio
0.53%
of 13F equity value
Holder Rank
#119
of 423 holders
Holding Since
Sep 2021
3 quarters on record
Voting authority
Sole 22%
Shared 0%
None 78%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Informed Momentum Co LLC holds $23,292,776 across 5 Drug Manufacturers - Specialty & Generic names. ALKS ranks #2 (24.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMRX |
Amneal Pharmaceuticals, Inc.
|
337,663 | $5,844,946 | |
| 2 | ALKS |
Alkermes plc.
This page
|
110,869 | $5,809,535 | |
| 3 | ETON |
Eton Pharmaceuticals, Inc.
|
158,045 | $5,721,229 | |
| 4 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
55,765 | $3,566,171 | |
| 5 | INDV |
Indivior Pharmaceuticals, Inc.
|
57,297 | $2,350,895 |
All Filings in ALKS
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,809,535 | 110,869 | Shares | Sole | 2026-08-13 | |
| 2025-03-31 | $5,251,996 | 159,055 | Shares | Sole | 2025-05-13 | |
| 2021-09-30 | $2,649,865 | 85,923 | Shares | Sole | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||